Dirk Huebner

CIK: 0001760345

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

APVO

Aptevo Therapeutics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

APVO
Aptevo Therapeutics Inc.
Aug 6, 2026
Exercise(M)
Direct
638 shares-
APVO
Aptevo Therapeutics Inc.
Aug 6, 2026
Tax Payment(F)
Direct
156 shares at avg. $4.07$634.92
APVO
Aptevo Therapeutics Inc.
Aug 6, 2025
Award(A)
Restricted Stock Unit
Direct
11.5K shares-

		Type	Shares	Price		Ownership
Aug 6, 2026	APVO Aptevo Therapeutics Inc.	Exercise(M)	638	-	$0	Direct
Aug 6, 2026	APVO Aptevo Therapeutics Inc.	Tax Payment(F)	156	$4.07	$635	Direct
Aug 6, 2025	APVO Aptevo Therapeutics Inc.	Award(A) Restricted Stock Unit	11,500	-	-	Direct

1-3 of 3 transactions

About Huebner Dirk

Huebner Dirk (SEC CIK 0001760345) files insider reports with the SEC as SVP, CMO of Aptevo Therapeutics Inc. (APVO).

Signal8 holds 3 ownership filings by Huebner Dirk (1 Form 3, 2 Form 4), filed between Jul 9, 2025 and Aug 10, 2026. Those filings report 3 transactions, from Aug 6, 2025 to Aug 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Huebner Dirk's filings is in SEATTLE, WA.

Recent filings by Huebner Dirk

Aug 6, 2026: Option exercise of APVO shares (Form 4, code M).
Aug 6, 2026: Tax withholding of APVO shares (Form 4, code F).
Aug 6, 2025: Grant or award of APVO derivative securities (Form 4, code A).

Other insiders filing for Aptevo Therapeutics Inc. (APVO)

Harsanyi Zsolt, Director
Lamothe Jeffrey G., President and CEO
Taylor Daphne, SVP, CFO
Kwon SoYoung, SVP, GC, BD & Corp Affairs
Grant Grady III, Director
White Marvin L, Executive Chair

How to read Form 4 transaction codes